Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1140 of 5804
-
Prepping the body before transplant: new study tests exercise program to boost recovery
Disease control Not yet recruitingCandidates for hematopoietic stem cell transplantation (HSCT) frequently experience declines in strength, physical function, and quality of life before the procedure. Many also present fatigue, limitations in daily activities, and an increased risk of complications during and aft…
Phase: NA • Sponsor: Hospital del Salvador • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for young cancer patients: drug may fix Chemo-Related low platelets
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of romiplostim N01 in treating chemotherapy-induced thrombocytopenia (CIT) in children and adolescents/young adults (CAYA; aged 6-24 years) with hematologic malignancies or solid tumors. The main questions it …
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Gene editing for hepatitis b: researchers track Long-Term safety
Disease control ENROLLING_BY_INVITATIONParticipants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.
Sponsor: Precision BioSciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New antibiotic tested against superbugs in chinese hospitals
Disease control Recruiting nowWhy This Study is Needed Some bacterial infections have become resistant to common antibiotics, making them very difficult to treat. This is a growing and serious health problem. A new combination drug, Aztreonam-Avibactam (we'll call it ATM-AVI), has been developed to fight thes…
Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New asthma drug QL2302 goes Head-to-Head with tezspire in major trial
Disease control Not yet recruitingThe goal of this clinical trial is to compare the efficacy and safety of QL2302 and Tezspire® in patients with uncontrolled severe asthma. The main questions it aims to answer are: * if the efficacy of QL2302 and Tezspire® are similar * if the safety of QL2302 and Tezspire® are …
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New study tests if removing stents earlier prevents fluid return after pancreatic necrosis treatment
Disease control Recruiting nowIn adults with walled-off pancreatic necrosis (WON) undergoing endoscopic ultrasound (EUS)-guided transluminal necrosectomy, does early removal of the lumen-apposing metal stent (LAMS) (at 2 weeks or immediately after the last necrosectomy) with placement of a double-pigtail plas…
Phase: NA • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental cell therapy takes on tough blood disorder
Disease control Not yet recruitingThis is a Phase I, single-arm, open-label, dose-escalation and dose-expansion study. The primary objective is to evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of YTS109 STAR-T cell therapy in patients with autoimmune hemolytic anemia who have…
Phase: PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Video game therapy could replace eye patches for lazy eye
Disease control Recruiting nowThis is a prospective, single-arm, non-inferiority clinical trial designed to evaluate the efficacy, safety, and adherence of AmblyoFix binocular digital therapy for the treatment of unilateral amblyopia in children aged 7 to 12 years. Outcomes will be compared against a retrospe…
Phase: NA • Sponsor: Eyesight Electronics • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could your gait and blood predict Alzheimer's? new study aims to find out
Diagnosis Not yet recruitingOur research hypothesis is as follows: A step - by - step screening strategy based on screening technologies can resolve the issue of insufficient efficiency in the traditional scale - based screening model. Meanwhile, performing pathological diagnoses on patients with suspected …
Sponsor: First Hospital of China Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
AI reads scans and genes to predict lung cancer drug success
Knowledge-focused Not yet recruitingThe main purpose of this study is to explore the value of multimodal imaging information and models in predicting the prognosis of EGFR-positive non-small cell lung cancer patients undergoing targeted therapy, providing a basis for selecting suitable populations for precise tumor…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
New scan could spot hidden myeloma lesions
Diagnosis Recruiting nowThis is a prospective, multicenter diagnostic imaging study designed to evaluate the diagnostic accuracy and clinical utility of BCMA-targeted positron emission tomography/computed tomography (PET/CT) in patients with multiple myeloma and related plasma cell disorders. The study …
Phase: PHASE2, PHASE3 • Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Can a Two-Drug punch knock out CMV faster in lung transplants?
Disease control Recruiting nowThe primary objective of the CLEAR-CMV trial is to evaluate the efficacy of letermovir therapy plus standard of care (SOC) antiviral compared to SOC plus placebo in achieving clearance of CMV viremia by week 3 in lung transplant recipients with active CMV infection.
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Radioactive drug lutathera tested against Hard-to-Treat meningioma
Disease control TerminatedThis is an open-label, multicenter, randomized, phase 2 clinical study to evaluate the efficacy of \[177Lu\]Lu-DOTATATE in patients with progressive grade 1-3 intracranial meningioma.
Phase: PHASE2 • Sponsor: RTOG Foundation, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New app aims to stop Kids' eyes from getting worse during screen time
Disease control Recruiting nowThe DYMOND study evaluates the safety and effectiveness of TrackSight™, a digital medical application designed to slow myopia (nearsightedness) progression in children during everyday screen use. TrackSight uses eye-tracking technology to keep central vision clear while subtly ad…
Phase: PHASE2 • Sponsor: NovaSight • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New device aims to break vaping addiction without drugs
Disease control Recruiting nowThis clinical trial evaluates the VapeAway system, a novel, multi-modal intervention designed to address the multifaceted nature of vaping addiction. VapeAway combines progressive nicotine tapering via proprietary filters, behavioral substitution with a sensory device (Fix Bar), …
Phase: PHASE2 • Sponsor: VapeAway • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Blood test may help personalize breast cancer therapy
Disease control Recruiting nowThis is an exploratory, ctDNA-guided, multi-stage clinical study designed to evaluate the clinical value of treatment decision-making based on circulating tumor DNA (ctDNA) variant allele frequency (VAF) dynamics in patients with HER2-negative metastatic breast cancer. All enrol…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can an antiviral drug stop RSV in vulnerable patients?
Disease control Recruiting nowThis phase II trial tests how well remdesivir works for treatment of respiratory syncytial virus (RSV) infection of the upper respiratory tract in patients receiving cellular or bispecific antibody therapy. Cellular or bispecific antibody therapies cause suppression of the immune…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a common ALS drug prevent chemotherapy brain fog?
Prevention Recruiting nowThis is a phase II single-arm, Phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining efficacy of riluzole in preventing cognitive dysfunction in subjects with cancer, who are receiving chemotherapy.
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New drug cocktail aims to tackle Hard-to-Treat cancers
Disease control Recruiting nowThis study aims to evaluate the safety, tolerability and efficacy of SHR-7787 in combination with other anti-tumor drugs in patients with malignant solid tumors.
Phase: PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New iron supplement could help celiac kids recover faster
Disease control Recruiting nowCeliac disease in children is frequently associated with iron deficiency and/or iron deficiency anemia due to intestinal malabsorption and chronic inflammation. Although a gluten-free diet is the standard treatment and can restore iron balance over time, there is currently no cle…
Phase: NA • Sponsor: Istituto Giannina Gaslini • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC